Emplicure AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMPLI.ST research report →
Companyemplicure.com
Emplicure AB (publ) engages in the research and development of pharmaceutical products primarily for the treatment of chronic pain in Sweden. The company provides Empli03, an oral buccal tablet; and Amp01, an oral nicotine pouches. Emplicure AB (publ) was incorporated in 2014 and is based in Uppsala, Sweden.
- CEO
- Hakan Engqvist
- IPO
- 2021
- HQ
- Uppsala, SE
Price Chart
Valuation
- Market Cap
- $46.47M
- P/E
- -0.39
- P/S
- 41.41
- P/B
- 0.85
- EV/EBITDA
- -1.14
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -442.87%
- Op Margin
- -2662.03%
- Net Margin
- -2597.33%
- ROE
- -167.22%
- ROIC
- -218.07%
Growth & Income
- Revenue
- $1.12M · 1302.50%
- Net Income
- $-29,142,000 · -44.42%
- EPS
- $-1.20 · 5.51%
- Op Income
- $-29,868,000
- FCF YoY
- -62.78%
Performance & Tape
- 52W High
- $1.43
- 52W Low
- $0.34
- 50D MA
- $0.42
- 200D MA
- $0.48
- Beta
- 1.32
- Avg Volume
- 105.76K
Get TickerSpark's AI analysis on EMPLI.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EMPLI.ST Coverage
We haven't published any research on EMPLI.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EMPLI.ST Report →